TETI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 8.828
EU - Europa 8.642
AS - Asia 4.749
SA - Sud America 1.823
AF - Africa 125
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.184
Nazione #
US - Stati Uniti d'America 8.689
RU - Federazione Russa 2.893
SG - Singapore 1.918
CN - Cina 1.676
BR - Brasile 1.637
IE - Irlanda 1.412
SE - Svezia 1.256
IT - Italia 656
DE - Germania 644
UA - Ucraina 552
HK - Hong Kong 541
FI - Finlandia 323
GB - Regno Unito 236
PL - Polonia 219
FR - Francia 217
VN - Vietnam 206
IN - India 74
AR - Argentina 70
CA - Canada 57
CZ - Repubblica Ceca 52
BD - Bangladesh 51
BE - Belgio 48
MX - Messico 44
ZA - Sudafrica 40
IQ - Iraq 38
TR - Turchia 32
EC - Ecuador 31
MA - Marocco 29
UZ - Uzbekistan 27
JP - Giappone 25
ES - Italia 24
PK - Pakistan 23
AT - Austria 21
CO - Colombia 21
NL - Olanda 18
VE - Venezuela 17
ID - Indonesia 16
AE - Emirati Arabi Uniti 14
CL - Cile 13
TN - Tunisia 13
JO - Giordania 12
DO - Repubblica Dominicana 11
UY - Uruguay 11
EG - Egitto 10
KE - Kenya 10
AZ - Azerbaigian 9
BG - Bulgaria 9
DZ - Algeria 9
IR - Iran 9
LT - Lituania 9
NP - Nepal 9
PY - Paraguay 9
PE - Perù 8
AL - Albania 7
KZ - Kazakistan 7
PS - Palestinian Territory 7
RO - Romania 7
CH - Svizzera 6
EU - Europa 6
IL - Israele 6
JM - Giamaica 6
KG - Kirghizistan 6
LV - Lettonia 6
OM - Oman 6
AM - Armenia 5
CR - Costa Rica 5
SN - Senegal 5
AU - Australia 4
BN - Brunei Darussalam 4
BO - Bolivia 4
LB - Libano 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
SA - Arabia Saudita 4
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
NO - Norvegia 3
TW - Taiwan 3
AO - Angola 2
BH - Bahrain 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KH - Cambogia 2
LK - Sri Lanka 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
Totale 24.167
Città #
Moscow 1.516
Dublin 1.411
Dallas 1.214
Chandler 1.128
Jacksonville 1.120
Singapore 977
Ashburn 813
Nyköping 687
Hong Kong 539
Beijing 526
Shenzhen 450
Messina 287
Dearborn 249
Princeton 243
Los Angeles 236
Cambridge 235
Medford 235
Boardman 213
Warsaw 213
Des Moines 195
Ann Arbor 188
The Dalles 169
Buffalo 141
Munich 115
São Paulo 114
New York 112
Woodbridge 80
Bremen 70
Ho Chi Minh City 69
Shenyang 60
Wilmington 57
Jinan 55
Tianjin 54
Belo Horizonte 49
Hanoi 49
Brussels 48
San Mateo 47
Brno 46
Helsinki 43
Redondo Beach 39
Turku 39
Rio de Janeiro 34
Nanjing 33
Pune 31
Brasília 30
Lancaster 30
Haikou 29
Nuremberg 29
Milan 27
Santa Clara 27
Hebei 26
Tashkent 26
Ningbo 25
Seattle 25
Houston 24
Johannesburg 24
Dong Ket 23
Tokyo 23
Zhengzhou 23
Brooklyn 22
Norwalk 22
Rome 22
Chennai 21
Curitiba 21
Düsseldorf 21
Stockholm 21
Council Bluffs 20
Frankfurt am Main 20
Montreal 20
London 18
Orem 18
Porto Alegre 18
San Jose 18
Taiyuan 18
Poplar 17
Campinas 16
Denver 16
Goiânia 16
Guangzhou 16
Hangzhou 16
Ribeirão Preto 16
Taizhou 16
Baghdad 14
Dhaka 14
Washington 14
Boston 13
Catania 13
Guarulhos 13
Campo Grande 12
Chicago 12
Guayaquil 12
Phoenix 12
Salvador 12
São José dos Campos 12
Vienna 12
Amman 11
Changsha 11
Montevideo 11
Nanchang 11
Quito 11
Totale 15.269
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 572
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 234
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 201
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 185
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 179
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 178
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 177
Analysis of the secretome of the group B Streptococcus 174
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 166
A new surface protein of Streptococcus suis identified by proteomics 165
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 161
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 161
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 161
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 156
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 156
Activation of the NLRP3 inflammasome by group B streptococci. 154
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 153
Analysis of the Streptococcus agalactiae exoproteome. 153
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 152
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 151
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 148
Anti-idiotypic vaccination against group B streptococci 140
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 139
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 137
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 136
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 136
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 136
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 135
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 134
Attivazione dell'inflammasoma da parte di S.pneumoniae 133
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 133
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 131
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 131
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 130
A meeting of mimics. 130
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 130
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 130
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 129
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 129
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 128
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 128
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 128
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 128
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 127
Immunogenic mimics of Brucella lipopolysaccharide epitopes 125
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 125
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 124
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 124
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. 124
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 124
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 124
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 124
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 123
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 123
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 121
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 121
The Phagocyte, Metchnikoff, and the Foundation of Immunology 121
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 120
Isolation of bacterial RNA from infected host tissues: application for transcriptomic studies of group B streptococci 119
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 119
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 118
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 118
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 118
The dual role of innate immunity during influenza 118
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 117
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 116
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 116
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 115
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. 115
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 114
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 113
Virus ed infezioni alimentari: il caso dell’epatite A 113
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 113
Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. 113
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 110
Effects of anti-cytokine treatments in neonatal sepsis models 110
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 110
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 110
Role of TLR13 in innate immune recognition of group B streptococci 110
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans 109
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 109
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 108
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 106
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 106
L'IFN-beta è fondamentale nel polarizzare la risposta citochinica verso il tipo 1 nel corso dell'infezione da cryptococcus neoformans. 105
Risposta dell'Ospite alle Infezioni Batteriche 104
Combating antibiotic resistance in S. pneumoniae infections: identification of pneumolysin binding peptides 104
Plasminogen binding and immunoprotective properties of the Mk-rich domain of PbsP, a cell wall protein from Streptococcus agalactiae 104
Role of host's immune response in infections caused by Streptococcus pneumoniae 104
Brucellosi:Aspetti medici e sociali 103
G(i) proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1 -> 3)-beta-D-glucan induced cytokine suppression 102
IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type I pattern during experimental cryptococcosis 102
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 102
Plasminogen- and fibronectin–binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cell 102
Induction of bactericidal antibodies by DNA Immunization with peptide mimics of the meningococcal capsule 102
[Genetic techniques for the production of influenza vaccines (author's transl)]. 102
Pro-interleukin-1 beta processing in response to streptococci is totally caspase-1 dependent in vitro, but not in vivo. 102
Caratterizzazione immunologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante “phage-display 101
Identification of fibrinogen binding protein fragments using genomic phage display libraries of Group B Streptococcus 100
Comparison of six systems for the identification of Enterobacteriaceae. 100
Totale 13.280
Categoria #
all - tutte 82.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021918 0 0 0 0 0 219 45 146 79 199 139 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20254.594 79 53 81 289 140 161 89 1.123 1.191 258 367 763
2025/20267.365 550 885 1.098 717 1.070 3.045 0 0 0 0 0 0
Totale 24.365